Compare Elevance Health Inc. Common Stock (ELV) vs T-Mobile Us Inc (TMUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elevance Health Inc. Common Stock vs T-Mobile Us Inc — how do they compare? Elevance Health Inc. Common Stock trades at $415.24 (market cap $86.95B), while T-Mobile Us Inc trades at $149.99 (market cap $183.76B). The key difference: T-Mobile Us Inc is far larger — about 2.1× Elevance Health Inc. Common Stock's market cap, and T-Mobile Us Inc pays the higher dividend (2.73%). Which is the better fit depends on your goals.
| ELV | TMUS | |
|---|---|---|
Market Cap | $86.95B | $183.76B |
Volume | 782,706 | 4,294,650 |
Sector | Health | Media |
52-Week High | $426.79 | $230.06 |
52-Week Low | $280.74 | $161.73 |
Enterprise Value | $107.76B | $300.37B |
Dividend Yield | 1.72% | 2.73% |
Typical Hold Time | — | 84 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
T-Mobile US (TMUS) trades at $167.62, up 1.02% with mixed technical signals showing bearish moving averages but neutral oscillators. The company demonstrates strong fundamentals with $88.31B revenue in 2025, 11.45% net margin, and consistent earnings beats in recent quarters. Recent developments include a 15% dividend increase to $1.17 per share and participation in a joint venture with AT&T and Verizon to expand satellite connectivity.
TMUS presents a compelling investment case with strong analyst support (79.6% buy ratings) and a $231.10 price target representing 38% upside. However, risks include $84.6B debt load, increasing debt-to-asset ratio (39.35% in 2025), and competitive pressures in the wireless industry. The stock offers growth potential through 5G expansion and AI-driven network improvements while maintaining dividend growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Elevance Health Inc. Common Stock
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →About T-Mobile Us Inc
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, creating T-Mobile Us. Following the merger, the firm provided nationwide service in major markets but spottier coverage elsewhere. T-Mobile spent aggressively on low-frequency spectrum, well suited to broad coverage, and has substantially expanded its geographic footprint. This expansion, coupled with aggressive marketing and innovative offerings, produced rapid customer growth. With the Sprint acquisition, the firm's scale now roughly matches its larger rivals: T-Mobile now serves 71 million postpaid and 21 million prepaid phone customers, equal to around 30% of the U.S. retail wireless market. In addition, the firm provides wholesale service to resellers.
Read more on TMUS →
